Overview
Location
United States, California, Pleasanton
Employees
51-200
Total raised
$17M
Founded date
2005
Funding Rounds 1
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 9
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Nov 28, 2012 | TriReme Medical Closes Funding Round | TriReme Medical, Inc., a Pleasanton, California and Singapore-based provider of innovative solutions for complex lesions, has closed a new round of financing. The company did not reveal the amount of the funding but it is known that has now... |
| Nov 27, 2012 | California medical device firm treating vascular diseases raises $18 million | “We are thrilled to have this major support from Asia in our efforts to create a next generation of interventional devices, ” said Eitan Konstantino, president and CEO of TriReme Medical, in a news release. According to TriReme’s website, t... |
| Oct 12, 2010 | Stent-based therapy developer TriReme Medical lands $17M | “This investment will allow us to ramp up our commercial activities worldwide, continue to develop internal R&D programs and pursue key regulatory approvals for our products in large markets such as the U.S., Japan and China,” CEO Eitan... |
| Oct 12, 2010 | TriReme rounds up $17 million | TriReme Medical Inc. completed its $17 million Series D financing round. Bio*One Capital PTE LTD led the financing; current investors Three Arch Partners and Adams Street Partners also contributed "strong support," according to Si... |
| Oct 12, 2010 | $17M for Stent Maker TriReme | Share Share on Facebook Share on Twitter LinkedIn Email Reprints TriReme Medical, a Pleasanton, CA-based developer of cardiovascular stents, catheters, and balloons, said this week that it has raised $17 million in Series D funding. The rou... |
| Oct 11, 2010 | TriReme Medical Closes $17M Series D Financing Round | TriReme Medical, Inc., a Pleasanton, California-based developer of innovative catheters and stents for the treatment of complex vascular disease, closed a $17m Series D financing round. The investment was led by Bio*One Capital, a subsidiar... |
| Stent-based therapy developer TriReme Medical lands $17M | TriReme Medical Inc. completed its $17 million Series D financing round. Bio*One Capital PTE LTD led the financing; current investors Three Arch Partners and Adams Street Partners also contributed “strong support,” according to Singapore-ba... | |
| California medical device firm treating vascular diseases raises $18 million | California medical device firm TriReme Medical, which also has offices in Singapore, announced Tuesday that it has raised $18 million. The round was led by Luminor Capital, a Singaporean private equity firm, new Asian investors as well as e... |